Diabetes and c-reactive protein. About 55 cases

ABSTRACT

C-reactive protein [CRP] is an inflammation protein. It is also a cardiovascular prognosis marker. It may direct physician in primary prevention of the diabetes' degenerative complications. We released a prospective study in diabetics followed at the extern consultation of internal medecine in Ariana Mahmoud El Matri Hospital. We excluded all patients presenting infectious, inflammatory or tumoral disease and those receiving treatment interfering with CRP. The method used in our hospital for measuring CRP was qualitative and semi-quantitative agglutination test. 35 patients were included in our study. 22 women [62.9%] and 13 men [37.5%]. The medium age of diabetes was 5 years. Only one patient had a CRP superior to 6 mg/ [24mg/l]. The statistic study didn't find any relationship between CRP and glycemia or HbAIC. In our study, the qualitative measure of the CRP didn't permit to predict the risk inherent in diabetes. However, recents studies using ultrasensible technic of CRP measure, showed a narrow correlation between the balance diabetes [Hb A1C] and the CRP. It is imperative to use the quantitative measure of this protein to limit arterial damage